Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
Tia — a startup providing hybrid primary care, OB/GYN services and mental health care to women — is now partnered with Cedars-Sinai in addition to UCSF Health and CommonSpirit Health. Under Tia's partnership model, the company combines its primary care with health systems' specialty care to reduce fragmentation and advance preventive health.
The siloed approach to women's healthcare is one of the main reasons the U.S. is unable to improve its record in this arena, according to Carolyn Witte, co-founder of startup Tia. In our latest episode, she discusses how her company is trying to solve this issue while also working to close the gaps that deepen health inequities in this space.
Tia, a concierge clinic combining primary care and OBGYN services, recently raised $100 million in funding. Amid a surge of financing into women’s health startups, CEO Carolyn Witte said investors’ perspectives are changing.
The two companies plan to open a clinic in Phoenix this fall, and additional locations over the next five years. To start, Tia will offer virtual care services in Phoenix.
Women’s health startup Tia plans to open two additional women’s health clinics after raising $24.28 million in series A funding. The company currently has one clinic in New York, but shifted to telehealth visits during the Covid-19 pandemic.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.